Public trial registry of the CCC-Munich

Trial AB04030 Masitinib GIST

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial
World
Trial acronym
:
AB04030 Masitinib GIST
World
Full title
:

A prospective, multicenter, randomized, open-label, active-controlled, 2-parallel group, phase III study to compare efficacy and safety of masitinib at 7.5 mg/kg/day to imatinib at 400 or 600 mg in treatment of patients with gastro-intestinal stromal tumour in first line medical treatment

World
NCT number
:
World
Responsible organization
:
3. Med 3. Med Ismaninger Str. 22 81675 München Germany Tum
Indications
Classification Code Description
- C20 Bösartige Neubildung des Rektums
- C17.9 Dünndarm, nicht näher bezeichnet
- C18.9 Kolon, nicht näher bezeichnet
- C16.9 Magen, nicht näher bezeichnet
- C15.9 Ösophagus, nicht näher bezeichnet
Trial design
World
Phase
:
III
Status
World
Status
:
Recruitment finished
Votes
Initiiation & lock
World
Date of lock (planned / actual)
:
Unknown / Unknown
Therapy
World
Therapy
:

Chemo,Sonstige,Zielgerichtet

Participants
Function Prename Surname Organization
World Responsible contact Philipp Jost Keine Organisationseinheit angegeben Magnifier